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Frequency and predictors of stroke after acute myocardial infarction:
specific aspects between in-hospital and postdischarge events
Olivier Hachet (1), Charles Guenancia (1), Thibault Leclercq (1), Yannick
Béjot (2), Yves Cottin (1), Luc Lorgis (1)
(1) CHU Dijon, Hôpital Bocage, Cardiologie, Dijon, France – (2) CHU
Dijon, Hôpital Bocage, Neurologie, Dijon, France
Purpose: Stroke is a serious complication after acute myocardial infarction
(AMI) and is closely associated with poor prognosis. This study aimed to
investigate the frequency, the characteristics and factors associated with in-
hospital and postdischarge stroke in patients with AMI. 
Methods: 8485 consecutive patients admitted in intensive care unit (ICU)
between January 2001 and June 2010 were included. Among other major
adverse cardiac events (MACE), both stroke and transient ischemic attack
(TIA) were collected during one-year follow-up. 
Results: 168 (1.98%) strokes were recorded during the first year of follow-up
after AMI. In-hospital strokes (IHS) occurred in 123 patients (1.4%), and 87% of
them in the first five days after admission in ICU. After multivariate logistic
regression analysis, IHS was independently associated with female sex (OR: 1.73,
95% CI: 1.19-2.51, p=0.004), previous stroke/TIA (OR: 2.21, 95% CI: 1.28-3.83,
p=0.004), LVEF (OR: 0.96, 95% CI: 0.95-0.98, p<0.001), new onset atrial fibril-
lation (AF) (OR: 1.99, 95% CI: 1.25-3.16, p=0.004) and C-reactive protein (CRP)
(OR 1.006, 95% CI: 1,003-1,009, p<0.001). Patients developing an in-hospital
stroke had an increased risk of death at one year after adjustment to other prog-
nostic factors (OR: 1.82, 95% CI: 1.05-3.15, p=0.031). Among surviving patients
(n=7808), postdischarge stroke (PDS) occurred in 45 patients (0.64%) within one-
year follow-up after AMI. After multivariate logistic regression analysis, PDS
was independently associated with age (OR: 1.04, 95% CI: 1.01-1.07, p=0.003),
previous stroke/TIA (OR: 3.69, 95% CI: 1.83-7.43, p<0.001) and systemic hyper-
tension (OR: 2.77, 95% CI: 1.26-6.08, p=0.011). During the entire study period
of ten years, the annual rate of stroke post-AMI remained stable. 
Conclusions: The present study describes specific predictors of in-hospital
and postdischarge stroke in patients with AMI, with a marked increase in the
risk of death, both during hospitalization and the year after AMI. After hos-
pital discharge, stroke remains a rare event and mostly associated with a high
cardiovascular risk.
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Background: Coronary Artery Anomalies (CAA), including anomalies of
coronary origin (ANOCOR) and ectasia or coronary aneurysms (ECTACOR)
share common entities. In coronary angiographies or autopsy series, their
prevalence range from 0.2 to 1.5%. Case control studies reported an associa-
tion between CAA and acute myocardial infarction (MI). We aimed to analyze
their prevalence, characteristics, therapeutic strategies and prognosis in
patients with acute MI.
Methods: All the consecutive patients admitted in the intensive care unit
of our hospital who underwent coronary angiography for an acute MI from
2001 to 2013 were retrospectively analysed. 
Results: Among the 9393 patients included during the study period,
80(0.92%) CAA were identified, including 37 (46%), ANOCOR and 43 (54%)
ECTACOR. Most were male (86%), with a mean age at 61±14 y, and 2.1±1.4
risk factors. The most frequent localisation of ANOCOR was the circumflex
artery (65%). The abnormal artery corresponds to the culprit lesion in 30% of
cases, and 46% had significant stenosis. In contrast, ECTACOR were mainly
localised on the right coronary artery (58%), and correspond to the culprit
lesion in 70% of the cases, and 60% had a significant stenosis. A minority, i.e.
41% of the significant lesions found on ANOCOR and 31% of those on
ECTACOR, received only a medical treatment, while 47% and 58% were
stented, or 12% and 12% underwent Coronary Artery Bypass Surgery, respec-
tively. After Percutaneous Coronary Intervention (PCI), final flow was TIMI
3 in most cases (94% and 81%, respectively). Only one patient died during the
hospital stay.
Conclusion: In our large retrospective study, the prevalence of CAAs is
consistent with older angiographic series. Culprit lesion was more frequently
associated with ECTACOR, but not with ANOCOR. The majority of signifi-
cant lesions was treated by coronary stenting with a successful angiographic
result.
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Metformin and contrast-induced nephropathy in diabetic patients
treated with primary percutaneous coronary intervention for ST seg-
ment elevation myocardial infarction: a multicentre study
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Laurent Feldman (3), Gabriel Steg (3), Yves Cottin (4), Ronan Roussel (2)
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Background: Contrast-induced nephropathy (CIN) is a frequent complica-
tion in patients undergoing percutaneous coronary intervention (PCI), associ-
ated with increased mortality. The impact of metformin, which has potential
interactions with renal function, on CIN remains to be investigated.
Aim: To analyze the association between chronic metformin treatment and
the development of CIN after primary PCI for ST segment elevation myocar-
dial infarction (STEMI).
Methods: 372 patients with diabetes mellitus (DM) treated with PCI <24H
in 2 coronary care units (Paris-Bichat and Dijon Hospital, France) were
included. Serum creatinine (Cr) was measured before and 48H after PCI. CIN
was defined as an increase in Cr of 44μmol/L (0.5mg/dL) or 25% over base-
line after PCI. Since PCI was urgent, metformin could not be withheld prior
to PCI but was usually stopped after PCI. 
Results: Mean age was 66±11 y, and 25% were women. 64% had hyper-
tension, 56% had DM duration > 5 year, and 26% had prior coronary artery
disease. Metformin and sulfonylurea were the most frequently used anti-
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diabetic chronic treatments (40% for both), and 27% were on insulin therapy.
The other antidiabetic medications, including glinide, glitazone, and acarbose
were rarely used (3%, 2%, and 5%, respectively). Mean baseline and post PCI
Cr levels were 102±52 and 122±81μmol/L. Rate of CIN was similar in
patients with or without metformin (21 vs 20%, respectively, p= 0.87).
Logistic regression for the risk of CIN taking into account classical risk fac-
tors showed no impact of chronic metformin therapy, even in stratified anal-
ysis in patients with chronic kidney disease. Hospital mortality was similar
between groups (7 vs 6%, respectively, p=0.69). Moreover, no case of lactic
acidosis was reported during the hospital stay.
Conclusion: In this multicentre study reflecting current clinical practice,
metformin treatment prior to primary PCI had no significant impact on CIN.
Larger studies are needed to confirm these findings.
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Aim: To compare cardiovascular (CV) outcomes after contemporary PCI
in patients with vs. without renal failure (RF) according to clinical presenta-
tion (ST-elevated myocardial infarction (STEMI), acute coronary syndrome
(ACS), and stable coronary artery disease (sCAD)).
Methods: Consecutive patients undergoing PCI with stent implantation
were prospectively included from 2007 to 2012. RF was defined by a CrCl
<60ml/min. The primary end-point was all cause-mortality. The secondary
endpoints were MACCE (cardiovascular death, myocardial infarction, stroke,
TLR), TLR (target lesion revascularization), and ARC definite/probable stent
thrombosis (ST) at one year.
Results: Among 5337 patients eligible, 1219 (23%) had PCI for STEMI,
1837 (34%) for ACS and 2281 (43%) for sCAD. There were 1441 (27%)
patients with RF. At one year, patients with RF had increased all-cause mor-
tality rates whatever the indication for PCI (Figure), with a 6 fold higher unad-
justed all-cause mortality rate in STEMI patients (41% vs. 7.5%) and a 3 fold
increase in ACS (19% vs. 6%) and sCAD (10% vs. 3%) patients compared to
noRF patients (p< 0.0001 for all comparisons). MACCE were also higher in
RF patients in each PCI indication (45% vs. 15% in STEMI, 23% vs. 14% in
ACS, and 14% vs. 9% in sCAD, p<0.05 for all). STEMI-noRF patients had
comparable mortality (p=0.209) and MACCE rates (p=0.658) than sCAD-RF
patients. TLR ranged from 5.5% to 7.4%, and definite/probable ST was <2.5%
without any difference in each PCI indication (p>0.05 for both). After multi-
variable analyses, RF was independently associated with an excess of death
with a more than doubled relative risk in STEMI compared to ACS and sCAD
patients (OR 5.3: CI 3.627-7.821 in STEMI vs. 2.1: CI 1.465-3.140 and 2.3:
CI: 1.507-3.469 in ACS and sCAD, respectively, p<0.0001).
Conclusion: RF is a stronger independent predictor of death after PCI in
patients with STEMI compared to patients with ACS and sCAD. CV prog-
nosis of sCAD-RF patients was found to be comparable to that of STEMI-
noRF patients.
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Outcome after drug-eluting stents for cardiac allograft vasculopathy
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Purpose: Cardiac allograft vasculopathy (CAV) constitues a primary cause
of death after heart transplantation. Bare metal stents (BMS) have been used
for revascularization, but they are associated with a high-risk of restenosis.
Limited data have shown favourable results with percutaneous coronary inter-
ventions (PCI) using drug-eluting stents (DES) in this specific population. Our
study focuses on intra-stent restenosis (ISR) for DES in CAV, on new revas-
cularisation and mortality.
Methods: 97 consecutive heart transplant recipients with successful PCI
were treated with DES (n=106) and BMS (n=25). They were prospectively
followed-up at one year after PCI. An angiographic lesion-based analysis at
12-month follow-up and a patient-based survival analysis were performed.
Results: The lesion-based analysis within 12 months after PCI showed an
ISR rate with BMS of 12% and an ISR rate with DES of 3.8%. The target
lesion revascularization (TLR) was 8% for BMS and 2.8% for DES. However,
the target vessel revascularization was higher (16.5%) and the remote lesion
revascularization was 8.7%, indicating the rapid occurrence of new significant
lesions. Cardiac mortality at one year was 9.7% and extra- cardiac mortality
was 2.9%.
Conclusions: DES are associated with a low rate of TLR and can safely
be used in heart transplant recipients with coronary artery disease. However,
new significant lesions occurred at one year indicating a progression of CAV. 
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Outcome of patients after resuscitation from out of hospital cardiac
arrest: the role of percutaneous coronary intervention in Clermont-
Ferrand university hospital
Amina Asadi (1), Nicolas Barber-Chamoux (2), Pascal Motreff (2)
(1) CHU Ibn Rochd, Cardiologie, Casablanca, Maroc – (2) CHU Gabriel
Montpied, Cardiologie, Clermont-Ferrand, France
Backround: The hospital cardiac arrest (ACEH) represent the leading
cause of death worldwide. Despite improvements in their care, the prognosis
of these patients remains very pejorative, including those who have received
initial resuscitation success.The objective of this study was to evaluate the
influence of emergency coronary angiography (CAG) and primary percuta-
neous coronary intervention (PCI) on the outcome of patients survivors after
out-of-hospital cardiac arrest and living in ICU in the Auvergne region namely
coronary angiography.
Methods: During 18 months, a cohort of surviving patients admitted alive
in Aceh and resuscitation was incorporated in the CHU Gabriel Montpied. All
demographics, pre-hospital and hospital were analyzed. The multivariate anal-
ysis of prognostic factors in this cohort used mainly the Cox model.
Results: 54 consecutive patients with out-of-hospital cardiac arrest survi-
vors underwent systematic emergency coronary angiography. Most (65%)
OHCA survivors had angiographic coronary artery disease: occlusion in
23 patients (43%) and significant stenosis in 12 patients (22%). Angioplasty
was attempted in 20 patients and was technically successful in 18. Chest pain
and the presence of ST-segment elevation were poor predictors of acute coro-
nary-artery occlusion. Hospital survival was 48%. By multivariable analysis,
use of PCI was an independent factor of survival (p=0.006). 
Conclusion: Acute coronary-artery occlusion is frequent in survivors of
out-of-hospital cardiac arrest and is predicted poorly by clinical and electro-
Abstract 0474 – Figure: Kaplan-Meier estimates of one-year mortality
